iGlarLixi (insulin glargine 100 U/ml plus lixisenatide) is effective and well tolerated in people with uncontrolled type 2 diabetes regardless of age: A REALI pooled analysis of prospective real-world data.
Diabetes, obesity & metabolism（2023）
摘要
iGlarLixi is effective and well tolerated in both younger and older people with uncontrolled T2D.
更多查看译文
关键词
age,elderly,fixed-ratio combination,iGlarLixi,insulin glargine,lixisenatide,real-world data,type 2 diabetes
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要